|
Dutasteride is the generic name of a drug which
is also known by the brand names Avodart, Avidart, Avolve, Duagen,
Dutas, Dutagen and Duprost. Avodart (Dutasteride) was developed by
GlaxoSmithKline for the treatment of medical conditions arising in
men’s body’s brought about by the conversion of testosterone into
dihydrotestosterone (DHT).
Along
with Finasteride, Dutasteride is a 5-alpha-reductase inhibitor. Both
drugs halt the effect of the 5-alpha-reductase enzyme. Blocking the
action of the enzyme stops the conversion of testosterone into
dihydrotestosterone (DHT). DHT causes the enlargement of the
prostate gland (Benign Prostatic Hyperplasia) and therefore halting
DHT conversion helps in the treatment of the condition.
|
Dutasteride / Avodart Price Comparison Chart |
|
Currency Converter |
|
Store
Name |
Generic / Brand |
Dosage |
Quantity |
Shipping and Payment Policy |
Price
/ Payment Type |
Price
Per Pill |
Press
the 'Details' button to purchase. |
|
4RX |
Generic |
0.5mg |
90 |
|
Worldwide except Canada and Mexico |
|
Visa Card Payments Only |
|
$104.00 |
$1.15 |
 |
|
Aclepsa |
Generic |
0.5mg |
90 |
|
Most
European Countries and USA |
|
Visa Card and Visa Electron Payments Only |
|
$104.00 |
$1.15 |
 |
|
Easy MD |
Generic |
0.5mg |
90 |
|
Worldwide |
|
Visa Card / Mastercard and Electronic Check
Payments |
|
$136.99 |
$1.52 |
 |
|
Quality RX |
Generic |
0.5mg |
90 |
|
Worldwide |
|
Visa Card and Visa Electron Payments Only |
|
$140.40 |
$1.56 |
 |
|
Quality RX |
Brand |
0.5mg |
90 |
|
Worldwide |
|
Visa Card and Visa Electron Payments Only |
|
$227.70 |
$2.53 |
 |
|
|
|
Dutasteride (0.5mg) blocks both isoforms of
5-alpha reductase unlike Finasteride which only blocks one.
However, findings from a GlaxoSmithKline study showed that Dutasteride was no more effective than Finasteride in the treatment
of Benign Prostatic Hyperplasia (BPH).
Whilst Finasteride has been approved for the treatment of Benign
Prostatic Hyperplasia and Male Pattern Baldness, Dutasteride has only been approved for the treatment of Benign Prostatic Hyperplasia.
Clinical trials for the use of Dutasteride as a hair loss treatment
were undertaken but were stopped in 2002. It is believed that
the clinical trials were halted on commercial grounds and not medical
ones. Results from phase II trials indicated that Dutasteride reported a superior hair count to Finasteride and is
believed to be 30% more effective than Propecia (Finasteride) for
hair regrowth.
|